Submitted by Anonymous (not verified) on 30 October 2026 - 13:30
Human medicines European public assessment report (EPAR): Oslif Breezhaler, indacaterol, Date of authorisation: 29/11/2009, Revision: 20, Status: Withdrawn
Source:
Human medicines European public assessment report (EPAR): Oslif Breezhaler, indacaterol, Date of authorisation: 29/11/2009, Revision: 20, Status: Withdrawn